| Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome L Fardet, L Galicier, O Lambotte, C Marzac, C Aumont, D Chahwan, ... Arthritis & rheumatology 66 (9), 2613-2620, 2014 | 1320 | 2014 |
| Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura M Scully, SR Cataland, F Peyvandi, P Coppo, P Knöbl, ... New England Journal of Medicine 380 (4), 335-346, 2019 | 912 | 2019 |
| Thrombotic thrombocytopenic purpura BS Joly, P Coppo, A Veyradier Blood, The Journal of the American Society of Hematology 129 (21), 2836-2846, 2017 | 759 | 2017 |
| Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies M Scully, S Cataland, P Coppo, J De La Rubia, KD Friedman, JK Hovinga, ... Journal of thrombosis and haemostasis 15 (2), 312-322, 2017 | 463 | 2017 |
| Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases MA Dragon-Durey, V Fremeaux-Bacchi, C Loirat, J Blouin, P Niaudet, ... Journal of the American Society of Nephrology 15 (3), 787-795, 2004 | 435 | 2004 |
| Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience P Coppo, M Schwarzinger, M Buffet, A Wynckel, K Clabault, C Presne, ... PloS one 5 (4), e10208, 2010 | 414 | 2010 |
| Thrombotic thrombocytopenic purpura JA Kremer Hovinga, P Coppo, B Lämmle, JL Moake, T Miyata, ... Nature reviews Disease primers 3 (1), 1-17, 2017 | 394 | 2017 |
| Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients S Rivière, L Galicier, P Coppo, C Marzac, C Aumont, O Lambotte, L Fardet The American journal of medicine 127 (11), 1118-1125, 2014 | 381 | 2014 |
| Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis … E Mariotte, E Azoulay, L Galicier, E Rondeau, F Zouiti, P Boisseau, ... The Lancet Haematology 3 (5), e237-e245, 2016 | 361 | 2016 |
| Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type Y Huang, A De Reyniès, L De Leval, B Ghazi, N Martin-Garcia, M Travert, ... Blood, The Journal of the American Society of Hematology 115 (6), 1226-1237, 2010 | 353 | 2010 |
| ISTH guidelines for treatment of thrombotic thrombocytopenic purpura XL Zheng, SK Vesely, SR Cataland, P Coppo, B Geldziler, A Iorio, ... Journal of Thrombosis and Haemostasis 18 (10), 2496-2502, 2020 | 342 | 2020 |
| Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic … S Ferrari, F Scheiflinger, M Rieger, G Mudde, M Wolf, P Coppo, JP Girma, ... Blood 109 (7), 2815-2822, 2007 | 316 | 2007 |
| Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura M Moatti-Cohen, C Garrec, M Wolf, P Boisseau, L Galicier, E Azoulay, ... Blood, The Journal of the American Society of Hematology 119 (24), 5888-5897, 2012 | 303 | 2012 |
| Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French … A Froissart, M Buffet, A Veyradier, P Poullin, F Provôt, S Malot, ... Critical care medicine 40 (1), 104-111, 2012 | 299 | 2012 |
| ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura XL Zheng, SK Vesely, SR Cataland, P Coppo, B Geldziler, A Iorio, ... Journal of Thrombosis and Haemostasis 18 (10), 2486-2495, 2020 | 275 | 2020 |
| Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide M Arca, L Fardet, L Galicier, S Rivière, C Marzac, C Aumont, O Lambotte, ... British journal of haematology 168 (1), 63-68, 2015 | 226 | 2015 |
| Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet … P Coppo, D Bengoufa, A Veyradier, M Wolf, A Bussel, GA Millot, S Malot, ... Medicine 83 (4), 233-244, 2004 | 192 | 2004 |
| Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura M Hie, J Gay, L Galicier, F Provôt, C Presne, P Poullin, G Bonmarchand, ... Blood, The Journal of the American Society of Hematology 124 (2), 204-210, 2014 | 184 | 2014 |
| JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma A Bouchekioua, L Scourzic, O De Wever, Y Zhang, P Cervera, ... Leukemia 28 (2), 338-348, 2014 | 173 | 2014 |
| A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP P Coppo, M Bubenheim, E Azoulay, L Galicier, S Malot, N Bigé, P Poullin, ... Blood, The Journal of the American Society of Hematology 137 (6), 733-742, 2021 | 170 | 2021 |
